Activism: latest news

Activism features

Activism in your own words

Activism news from aidsmap

  • France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic

    France is launching a new study which will enrol 3000 new pre-exposure prophylaxis (PrEP) users over the next three years, Jean-Michel Molina told the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris this week. Whereas previous studies, ...

    28 July 2017 | Roger Pebody
  • Hope overshadowed – the US PrEP Summit

    The US National HIV PrEP Summit, which took place in early December in San Francisco, was one of the most extraordinary HIV meetings I have ever been to. This first-ever gathering of 600 people involved in ...

    31 January 2017 | Gus Cairns
  • Policy makers’ inaction is leading people to take PrEP ‘in the wild’

    An increasing number of gay men and others at risk of HIV are seeking to protect their health with PrEP (pre-exposure prophylaxis), but the lack of PrEP provision and lack of regulatory approval in many countries is leading ...

    19 October 2016 | Roger Pebody
  • Gains in curbing HIV epidemic could be lost without continued commitment, AIDS 2016 speakers say

    Participants at the 21st International AIDS Conference (AIDS 2016), taking place this week in Durban, South Africa, reviewed the remarkable gains that have been made in access to HIV treatment and new prevention tools since the conference was last held ...

    19 July 2016 | Liz Highleyman
  • People who inject drugs have other priorities ahead of PrEP

    People who inject drugs have fundamental concerns about HIV pre-exposure prophylaxis (PrEP) and the manner in which it is being promoted, according to a consultation conducted by the International Network of People who Use Drugs (INPUD). With limited availability ...

    17 June 2016 | Roger Pebody
  • England’s PrEP policy in disarray after NHS U-turn

    Activists, individuals at risk of HIV, and clinicians have reacted with anger to an official U-turn on provision of HIV pre-exposure prophylaxis (PrEP). NHS England officials have refused to allow a draft policy on PrEP to go forward for ...

    22 March 2016 | Roger Pebody
  • London sexual health clinics step up their support for people buying PrEP online

    Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring to PrEP users. This is in a context of increasing frustration with ...

    29 January 2016 | Roger Pebody
  • France approves PrEP

    In a historic move, France has become the first country outside the USA, and the first country with a centrally-organised, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it.The French Minister of Health, ...

    24 November 2015 | Gus Cairns
  • Harm reduction conference calls for political leadership to reform drugs policy

    The biggest challenges to harm reduction are drugs policy and drugs laws, the Malaysian harm reduction leader Dr Adeeba Kamarulzaman told the 24th International Harm Reduction Conference in Kuala Lumpur last week.Numerous speakers said that punitive and prohibitionist drugs policies have restricted ...

    27 October 2015 | Roger Pebody
  • How does a ‘human rights based approach’ work out on the ground? Lessons from South Africa

    While international rhetoric on HIV and AIDS frequently invokes human rights, putting these ideas into practice in specific settings remains challenging, according to a process evaluation of an intervention in rural South Africa published in the October issue of ...

    29 October 2014 | Roger Pebody
More news

Activism news selected from other sources

  • PrEP-ing for HIV prevention in Ireland

    Lack of access to HIV pre-exposure prophylaxis (PrEP) is presenting dilemmas for the HSE, clinicians, the medicines regulator and those seeking the medication in Ireland. A recent memo to healthcare professionals sent on behalf of the HSE’s Working Group on HIV pre-exposure prophylaxis (PrEP), discouraging them from directing patients to the activist-led website www.iwantPrEPnow.co.uk for information on sourcing pre-emptive antiretroviral therapy online, is a talking point among campaigners advocating for access.

    18 September 2017 | The Medical Independent
  • Capturing the Wild Sadness of the AIDS Crisis at Its Height

    It was not until decades later — after drug advances and cultural changes had dulled the sharp edge of the AIDS crisis, after the disease and those who fought it became something that many people saw as history — that the photographer Stephen Barker realized that he had been creating a photo project about AIDS and the people he met at ACT UP, the AIDS advocacy group.

    13 September 2017 | Time
  • Watch: USCA Plenary Halted by Trans Activists

    The United States Conference on AIDS (USCA), celebrating thirty years of teaching practical skills to HIV service providers, found itself the target of old-school activism on Friday when transgender activists stopped the plenary program to voice their frustrations about being underrepresented by the organizations in attendance and by the conference itself.

    11 September 2017 | My Fabulous Disease
  • 5 things you need to know to join the IMPACT trial

    The PrEP IMPACT trial is a clinical trial in England and will operate differently to the ways you usually get sexual health services. You'll need to meet eligibility criteria to go on the trial, and you'll need to read and sign paperwork before you start. You'll also be asked to visit your trial clinic every 3 months for HIV and STI tests. The PrEP IMPACT trial starts in September 2017 – and there are 5 important sets of things you need to know if you’re thinking about joining the trial.

    07 September 2017 | PrEPster
  • Did HIV Pharma “Pay to Delay” Generic Truvada?

    AIDS activists urge the N.Y. attorney general to investigate possible antitrust violations regarding the HIV med used as PrEP.

    04 September 2017 | Poz
  • AIDS activists urge N.Y. attorney general to probe Gilead for antitrust violations

    A group of prominent AIDS activists is urging the New York attorney general to investigate Gilead Sciences (GILD) for potential antitrust violations in connection with deals the drug maker struck with rivals that sought to sell generic versions of a best-selling HIV treatment.

    30 August 2017 | STAT
  • Obituary: Prudence Mabele

    “She was an incredibly articulate, authentic, and real voice demonstrating the struggles and needs of many people, particularly women living with HIV and affected by gender-based violence”, Shaun Mellors said. “For many of us, she was the activist that we aimed to become.”

    22 August 2017 | The Lancet (free registration required)
  • HIV fight continues, TAC pledge to Prudence Mabele

    Treatment Action Campaign (TAC) activists have pledged to continue the fight against HIV, Aids, and Tuberculosis (TB) in honour of activist Prudence Mabele and researcher Mark Wainberg.

    24 July 2017 | Independent Online
  • Prudence Mabele, leading HIV activist, dies

    South Africa's leading advocate for people living with HIV and Aids and a respected gender activist, Prudence Nobantu Mabele, has died from pneumonia at the age of 46.

    13 July 2017 | eNCA
  • AIDS activists fought for public recognition. This exhibit shows their lives at home

    After a long day of marching, what do protesters do when they go home? In the imagination of painter Hugh Steers, they return to the tender care of lovers. Or they may return to a routine of medications. Historian Stephen Vider reveals these and other intimate narratives in the lives of individuals affected by the HIV/AIDS epidemic. His curation of “AIDS at Home: Art and Everyday Activism” opened on May 23 at the Museum of the City of New York.

    10 July 2017 | PBS Newshour
More news


Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.